Utilization of Evidence Blueprint Initiative to Transform Capability Development in AstraZeneca Spain [0.03%]
利用证据蓝图计划改造阿斯利康西班牙分公司的能力开发
Jesús Medina,Joaquín Sánchez-Covisa,Javier Nuevo et al.
Jesús Medina et al.
The role of Medical Affairs (MA) has shifted from traditional evidence dissemination to an integrated process leveraging real-world data (RWD) and diverse data sources. To adapt and lead this shift, AstraZeneca (AZ) Spain recognized the ess...
Treatment Persistence in Rheumatoid Arthritis Before and After Etanercept Biosimilar Introduction: A Nationwide Australian Real-World Study [0.03%]
益赛普生物类似药引入前后类风湿性关节炎治疗依从性的变化:一项澳大利亚全国真实世界研究
Chin Hang Yiu,Bella D Ianni,Richard O Day et al.
Chin Hang Yiu et al.
Background: Australia has one of the highest rates of rheumatoid arthritis (RA) worldwide. Etanercept, a widely used biologic for severe RA, has had a publicly subsidised biosimilar available in Australia since 2017. Howe...
Pioneering the Future of Medical Affairs: A Strategic Transformation to Meet the Spanish Healthcare Ecosystem's Evolving Trends [0.03%]
开创医学事务的未来:战略转型以适应西班牙医疗生态系统的发展趋势
Ana Pérez Domínguez,Jorge Marinich,Gema Monteagudo et al.
Ana Pérez Domínguez et al.
The role of medical affairs (MA) in the pharmaceutical industry is undergoing a profound transformation, driven by the increasing complexity of healthcare ecosystems, the rise of digital technologies, and the need for enhanced stakeholder e...
Combating Antimicrobial Resistance: Role of Key Stakeholders with Focus on the Pharmaceutical Sector [0.03%]
抗菌药物耐药性的防控:以制药行业为重点的各参与方的作用
Sangeeta Sharma,Maneesh Paul Satyaseela,Ranga Reddy Burri et al.
Sangeeta Sharma et al.
Antimicrobial resistance is a pressing global health threat fueled by a complex interplay of biological, social, and economic factors. Despite widespread recognition of its impact, the antimicrobial resistance crisis continues to deepen bec...
Correction: Challenges to Establishing Pharmaceutical Medicine as a Profession: Needs for Professional Identity and a Career Pathway: Role of Education and Training [0.03%]
订正:建立药学医学职业的挑战:需要专业身份和职业路径:教育和培训的作用
Honorio Silva,Varvara Baroutsou,Domenico Criscuolo et al.
Honorio Silva et al.
Published Erratum
Pharmaceutical medicine. 2025 Jul 3. DOI:10.1007/s40290-025-00569-8 2025
Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators [0.03%]
四种国家监管机构对药品相同危害效果的安全警告比较研究
Lucy T Perry,Alice Bhasale,Ashleigh Hooimeyer et al.
Lucy T Perry et al.
Background: Safety advisories provide critical information to clinicians and patients on the harms of medicines. Previous research has shown that national regulators vary in their decisions to issue safety warnings. Howev...
Transforming Care in China by Using Public-Private Partnerships to Unlock the Power of Patient-Centered Real-World Data [0.03%]
利用公私合作伙伴关系的力量解锁以患者为中心的真实世界数据来转型中国医疗护理模式
Maigeng Zhou,Feng Sun,Fuzhong Xue et al.
Maigeng Zhou et al.
The transformation of China's healthcare system is increasingly driven by the development of real-world data (RWD) and real-world evidence (RWE). In the context of the "Healthy China 2030" initiative, which emphasizes addressing the growing...
A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology [0.03%]
药品不良反应及药物流行病学的产学研合作模型
Alfred I Neugut,Vinu George,Judith S Jacobson et al.
Alfred I Neugut et al.
Collaborations between academia and the pharmaceutical industry are common for drug development and clinical trials, but rare for pharmacovigilance. Here we describe a novel model for collaboration between academia and the pharmaceutical in...
Correction: Shifting Paradigms in Medicines Development as a Profession: To Be or Not To Be [0.03%]
纠正:医药开发作为职业的范式转换:在犹豫中前进还是果断退出
Soneil Guptha,Domenico Criscuolo
Soneil Guptha
Published Erratum
Pharmaceutical medicine. 2025 May 20. DOI:10.1007/s40290-025-00570-1 2025
Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation [0.03%]
为什么医药行业需要实施科学以实现可持续创新
Anthony J Messina
Anthony J Messina